Bertheau P - Search Results

1

A refined molecular taxonomy of breast cancer.

Guedj M, Marisa L, de Reynies A, Orsetti B, Schiappa R, Bibeau F, MacGrogan G, Lerebours F, Finetti P, Longy M, Bertheau P, Bertrand F, Bonnet F, Martin AL, Feugeas JP, Bièche I, Lehmann-Che J, Lidereau R, Birnbaum D, Bertucci F, de Thé H, Theillet C. Guedj M, et al. Among authors: bertheau p. Oncogene. 2012 Mar 1;31(9):1196-206. doi: 10.1038/onc.2011.301. Epub 2011 Jul 25. Oncogene. 2012. PMID: 21785460 Free PMC article.

2

[Tissue microdissection: application to the study of cancer of the breast].

Bertheau P, de Thé H, de Roquancourt A, Lerebours F, Espié M, Janin A. Bertheau P, et al. Ann Pathol. 1999;19(5 Suppl):S3-6. Ann Pathol. 1999. PMID: 10599450 French. No abstract available.

3

Microdissection and breast cancer.

Bertheau P, Rivet J, de Roquancourt A, de Thé H, Espié M, Janin A. Bertheau P, et al. J Mol Med (Berl). 2000;78(7):B31. J Mol Med (Berl). 2000. PMID: 11043391 No abstract available.

4

Allelic loss detection in inflammatory breast cancer: improvement with laser microdissection.

Bertheau P, Plassa LF, Lerebours F, de Roquancourt A, Turpin E, Lidereau R, de Thé H, Janin A. Bertheau P, et al. Lab Invest. 2001 Oct;81(10):1397-402. doi: 10.1038/labinvest.3780353. Lab Invest. 2001. PMID: 11598152 Free article.

5

Effect of mutated TP53 on response of advanced breast cancers to high-dose chemotherapy.

Bertheau P, Plassa F, Espié M, Turpin E, de Roquancourt A, Marty M, Lerebours F, Beuzard Y, Janin A, de Thé H. Bertheau P, et al. Lancet. 2002 Sep 14;360(9336):852-4. doi: 10.1016/S0140-6736(02)09969-5. Lancet. 2002. PMID: 12243922

6

Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer.

Turpin E, Bièche I, Bertheau P, Plassa LF, Lerebours F, de Roquancourt A, Olivi M, Espié M, Marty M, Lidereau R, Vidaud M, de Thé H. Turpin E, et al. Among authors: bertheau p. Oncogene. 2002 Oct 24;21(49):7593-7. doi: 10.1038/sj.onc.1205932. Oncogene. 2002. PMID: 12386822

7

Evidence of chromosome regions and gene involvement in inflammatory breast cancer.

Lerebours F, Bertheau P, Bieche I, Driouch K, De The H, Hacene K, Espie M, Marty M, Lidereau R. Lerebours F, et al. Among authors: bertheau p. Int J Cancer. 2002 Dec 20;102(6):618-22. doi: 10.1002/ijc.10729. Int J Cancer. 2002. PMID: 12448004

8

Two prognostic groups of inflammatory breast cancer have distinct genotypes.

Lerebours F, Bertheau P, Bieche I, Plassa LF, Champeme MH, Hacene K, Toulas C, Espie M, Marty M, Lidereau R. Lerebours F, et al. Among authors: bertheau p. Clin Cancer Res. 2003 Sep 15;9(11):4184-9. Clin Cancer Res. 2003. PMID: 14519644

9

Prognostic significance of a combined clinicopathologic score for response to primary systemic therapy in locally advanced breast cancer.

Bertheau P, Lerebours F, Mounier N, de Roquancourt A, Espié M, Clot P, Servant JM, Misset JL, Marty M, Janin A. Bertheau P, et al. Oncol Rep. 2005 Aug;14(2):513-20. Oncol Rep. 2005. PMID: 16012739

10

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.

Bertheau P, Turpin E, Rickman DS, Espié M, de Reyniès A, Feugeas JP, Plassa LF, Soliman H, Varna M, de Roquancourt A, Lehmann-Che J, Beuzard Y, Marty M, Misset JL, Janin A, de Thé H. Bertheau P, et al. PLoS Med. 2007 Mar;4(3):e90. doi: 10.1371/journal.pmed.0040090. PLoS Med. 2007. PMID: 17388661 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters